What Happened?
, -based Annovis Bio Appointed Andrew Walsh as Vice President Finance
About the Company
Annovis Bio is developing a drug for Alzheimers Disease, Parkinsons Disease and other neurodegenerative diseases that inhibits more than one neurotoxic protein and, thereby, improves the information highway of the nerve cell, known as axonal transport.
About the Person
Andrew Walsh is Vice President Finance at Annovis Bio. Previously, Andrew held various senior HR leadership roles in the industry.
Info Source
News
Short Profile